Anna Łusakowska - Concepedia

Author

Anna Łusakowska

Also Known As

A Lusakowska, A. Lusakowska, A. Łusakowska, ANNA ŁUSAKOWSKA, Anna Lusakowska, Anna Łusakowska, Lusakowska, Anna, Marcin Sobieraj, Łusakowska, Anna

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Medical University of Warsaw University Medical Center Freiburg Newcastle University University of Belgrade Polish Academy of Sciences

AŁ

About

Anna Łusakowska is an author at Medical University of Warsaw specializing in medicine, health sciences, and rehabilitation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.4K
2	Health Sciences	4	4	177
3	Applied Physiology	2	2	63
4	Engineering	1	1	717
5	Public Health	1	1	102

Anna Łusakowska

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations Catherine L. Bladen, David Salgado, Soledad Monges, Human Mutation Dmd MutationsTrial PlanningEngineeringMendelian DisorderGenetic Disorder	2015	717
A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients Klaus Zerres, Sabine Rudnik‐Schöneborn, Eric Forrest, Journal of the Neurological Sciences Neuromusculoskeletal DisorderSpinal DisorderNatural HistoryPediatricsCollaborative Study	1997	282
Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database Zaïda Koeks, Catherine L. Bladen, David Salgado, Journal of Neuromuscular Diseases	2017	171
Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial Enrico Bertini, Éric Dessaud, Eugenio Mercuri, The Lancet Neurology Placebo-controlled Phase 2Chronic Musculoskeletal ConditionType 2Clinical TrialsSpinal Muscular Atrophy	2017	114
Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness Ana Töpf, Katherine Johnson, Adam Bates, Genetics in Medicine	2020	105
The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia Catherine L. Bladen, Karen Rafferty, Volker Straub, Human Mutation Rare DiseasesDmd RegistriesDuchenne Muscular DystrophyPrecision MedicineClinical Trials	2013	103
Mapping the differences in care for 5,000 Spinal Muscular Atrophy patients, a survey of 24 national registries in North America, Australasia and Europe Catherine L. Bladen, Rachel Thompson, J. Jackson, Journal of Neurology Spine CarePrimary CareHealth PolicyMedicineInternational Health	2013	102
European Cross-Sectional Survey of Current Care Practices for Duchenne Muscular Dystrophy Reveals Regional and Age-Dependent Differences Julia Vry, K. Gramsch, Sunil Rodger, Journal of Neuromuscular Diseases	2016	94
Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy Anna Łusakowska, Maria Jędrzejowska, Anna Kamińska, Orphanet Journal of Rare Diseases	2021	71
Effects of repeated abobotulinumtoxinA injections in upper limb spasticity Jean‐Michel Gracies, Michael W. O’Dell, Michele Vecchio, Muscle & Nerve	2017	68

Page 1